SPP1 and colonic neoplasm: The anti-OPN monoclonal antibody AOM1 blocks the αvβ3 binding site as well as the thrombin cleavage site of OPN, thus effectively inhibiting OPN-αvβ3 integrin interaction and reducing cell migration in colon cancer [151].